Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 71610-839

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 71610-839). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0839 30)

Label for Zolpidem Tartrate ER, USP 6.25 mg extended release tablets in a package of 30 tablets. The label includes storage instructions, manufacturer Aphena Pharma Solutions - Tennessee, LLC, and cautions about controlled substance status and habit-forming potential. The NDC number is 71610-839-30.*

FDA Label Image

Zolpidem Tartrate (8bb9d44d 6ee5 4174 8d42 52078de66779 01)

Chemical structure diagram showing the molecular structure of zolpidem tartrate, including the zolpidem molecule and the tartaric acid component on the right side.*

FDA Label Image

Im-2 (8bb9d44d 6ee5 4174 8d42 52078de66779 02)

A pharmacokinetic graph showing zolpidem plasma concentrations (ng/mL) over time (hours) comparing 12.5 mg zolpidem tartrate extended-release tablets and 10 mg zolpidem tartrate immediate release tablets. The plot illustrates concentration changes for both formulations from 0 to 8 hours post-dose.*

FDA Label Image

Aphena (Aphena)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.